Literature DB >> 23387442

Hemianopic inner retinal thinning after stroke.

Masaki Tanito, Akihiro Ohira.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23387442     DOI: 10.1111/aos.12039

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  5 in total

1.  Macular Ganglion Cell Layer and Peripapillary Retinal Nerve Fibre Layer Thickness in Patients with Unilateral Posterior Cerebral Artery Ischaemic Lesion: An Optical Coherence Tomography Study.

Authors:  Rita Anjos; Luisa Vieira; Livio Costa; André Vicente; Arnaldo Santos; Nuno Alves; Duarte Amado; Joana Ferreira; João Paulo Cunha
Journal:  Neuroophthalmology       Date:  2016-01-19

2.  Chromatic pupillography in hemianopia patients with homonymous visual field defects.

Authors:  Fumiatsu Maeda; Carina Kelbsch; Torsten Straßer; Karolína Skorkovská; Tobias Peters; Barbara Wilhelm; Helmut Wilhelm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-30       Impact factor: 3.117

3.  Retinal Ganglion Cell Atrophy in Homonymous Hemianopia due to Acquired Occipital Lesions Observed Using Cirrus High-Definition-OCT.

Authors:  Tsutomu Yamashita; Atsushi Miki; Katsutoshi Goto; Syunsuke Araki; Go Takizawa; Yoshiaki Ieki; Junichi Kiryu; Akio Tabuchi; Yasuyuki Iguchi; Kazumi Kimura; Yoshiki Yagita
Journal:  J Ophthalmol       Date:  2016-05-04       Impact factor: 1.909

Review 4.  Rhodopsin: A Potential Biomarker for Neurodegenerative Diseases.

Authors:  Cameron Lenahan; Rajvee Sanghavi; Lei Huang; John H Zhang
Journal:  Front Neurosci       Date:  2020-04-15       Impact factor: 4.677

5.  Sectoral analysis of the retinal nerve fiber layer thinning and its association with visual field loss in homonymous hemianopia caused by post-geniculate lesions using spectral-domain optical coherence tomography.

Authors:  Katsutoshi Goto; Atsushi Miki; Tsutomu Yamashita; Syunsuke Araki; Go Takizawa; Masaki Nakagawa; Yoshiaki Ieki; Junichi Kiryu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-07       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.